Exponent, Inc. (EXPO) Tops Q1 EPS by 12c, provides outlook

Exponent, Inc. (NASDAQ: EXPO) reported Q1 EPS of $0.59, $0.12 better than the analyst estimate of $0.47. Revenue for the quarter came in at $144.9 million versus the consensus estimate of $125.98 million.

Outlook:

For the second quarter of 2024, as compared to the same period one year prior, Exponent anticipates:

Revenues before reimbursements to be flat to up in the low-single digits; and,
EBITDA1 to be 27.25% to 28.25% of revenues before reimbursements.

For the fiscal year 2024 we are increasing our revenue and margin guidance. Exponent anticipates:

Revenues before reimbursements to grow in the low-single digits; and,
EBITDA1 to be 26.25% to 27.0% of revenues before reimbursements.

For earnings history and earnings-related data on Exponent, Inc. (EXPO) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• SEI Investments (SEIC) PT Raised to $115 at Morgan Stanley
• ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half